87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Hospital stay or home care? AI helps tailor myeloma stem cell treatment safely

Hospital stay or home care? AI helps tailor myeloma stem cell treatment safely

byUniversity of GöttingenTemporal profile and distribution of adverse event occurrences. Credit:npj Digital Medicine(2026). DOI: 10.1038/s41746-026-02394-yMultiple myeloma is a cancer in which plasma

Hospital stay or home care? AI helps tailor myeloma stem cell treatment safely

byUniversity of GöttingenTemporal profile and distribution of adverse event occurrences. Credit:npj Digital Medicine(2026). DOI: 10.1038/s41746-026-02394-yMultiple myeloma is a cancer in which plasma
Immunotherapy plus chemo cuts stage three dMMR colon cancer recurrence by 50%

Immunotherapy plus chemo cuts stage three dMMR colon cancer recurrence by 50%

byMayo ClinicCredit: Pixabay/CC0 Public DomainColon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than

Immunotherapy plus chemo cuts stage three dMMR colon cancer recurrence by 50%

byMayo ClinicCredit: Pixabay/CC0 Public DomainColon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than
Pesticides and cancer: Study reveals the biological mechanisms behind an environmental health risk

Pesticides and cancer: Study reveals the biological mechanisms behind an environmental health risk

byPasteur InstituteCredit: Mark Stebnicki from PexelsA new study, published inNature Health, reveals a strong link between exposure to agricultural pesticides in the environment and the risk of develo

Pesticides and cancer: Study reveals the biological mechanisms behind an environmental health risk

byPasteur InstituteCredit: Mark Stebnicki from PexelsA new study, published inNature Health, reveals a strong link between exposure to agricultural pesticides in the environment and the risk of develo
AI model can predict chemotherapy benefit in breast cancer

AI model can predict chemotherapy benefit in breast cancer

byTechnion - Israel Institute of TechnologyStudy cohorts, deep learning system architecture, and performance evaluation on TAILORx-Test. Credit:The Lancet Oncology(2026). DOI: 10.1016/s1470-2045(25)00

AI model can predict chemotherapy benefit in breast cancer

byTechnion - Israel Institute of TechnologyStudy cohorts, deep learning system architecture, and performance evaluation on TAILORx-Test. Credit:The Lancet Oncology(2026). DOI: 10.1016/s1470-2045(25)00
An avatar to study pediatric brain cancer may soon be a reality

An avatar to study pediatric brain cancer may soon be a reality

byUniversity of TrentoA summary of pPDT and pPDXT generation, amplification and biobanking and their use in drug screening and other applications. Credit:Nature Protocols(2026). DOI: 10.1038/s41596-02

An avatar to study pediatric brain cancer may soon be a reality

byUniversity of TrentoA summary of pPDT and pPDXT generation, amplification and biobanking and their use in drug screening and other applications. Credit:Nature Protocols(2026). DOI: 10.1038/s41596-02
Early results from a trial of active surveillance for low-risk ductal carcinoma in situ are 'reassuring'

Early results from a trial of active surveillance for low-risk ductal carcinoma in situ are 'reassuring'

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described ear

Early results from a trial of active surveillance for low-risk ductal carcinoma in situ are 'reassuring'

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers leading a trial of active surveillance for ductal carcinoma in situ (DCIS) have described ear
PSMA therapy delays hormone therapy in prostate cancer, clinical trial finds

PSMA therapy delays hormone therapy in prostate cancer, clinical trial finds

byRadboud UniversityNuclear medicine physician James Nagarajah from Radboudumc in the clinics. Credit: RadboudumcWhere previous research showed that PSMA therapy for prostate cancer can prolong the li

PSMA therapy delays hormone therapy in prostate cancer, clinical trial finds

byRadboud UniversityNuclear medicine physician James Nagarajah from Radboudumc in the clinics. Credit: RadboudumcWhere previous research showed that PSMA therapy for prostate cancer can prolong the li
After allogeneic transplant, VIC-1911 regimen shows low severe GVHD and no relapse

After allogeneic transplant, VIC-1911 regimen shows low severe GVHD and no relapse

byRoswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainResults of a Phase I clinical trial show that patients who undergo a blood stem cell transplant involving a donor have a low

After allogeneic transplant, VIC-1911 regimen shows low severe GVHD and no relapse

byRoswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainResults of a Phase I clinical trial show that patients who undergo a blood stem cell transplant involving a donor have a low
TYK2 protein suppresses breast cancer metastasis by sensing extracellular stiffness, research finds

TYK2 protein suppresses breast cancer metastasis by sensing extracellular stiffness, research finds

by Miles Martin,University of California - San DiegoIn healthy tissues, seen in the top two panels here, TYK2 (green) is found on the cell membrane and colocalizes with E-cadherin (red), a protein tha

TYK2 protein suppresses breast cancer metastasis by sensing extracellular stiffness, research finds

by Miles Martin,University of California - San DiegoIn healthy tissues, seen in the top two panels here, TYK2 (green) is found on the cell membrane and colocalizes with E-cadherin (red), a protein tha
A new immunotherapy target? How SRC-3 in Tregs may reshape solid-tumor treatment

A new immunotherapy target? How SRC-3 in Tregs may reshape solid-tumor treatment

by Ana María Rodríguez,Baylor College of MedicineThe loss of SRC-3 in Treg leads to immune suppression of glioblastoma in mice: (A) Experimental design for the orthotopic injection of glioblastoma cel

A new immunotherapy target? How SRC-3 in Tregs may reshape solid-tumor treatment

by Ana María Rodríguez,Baylor College of MedicineThe loss of SRC-3 in Treg leads to immune suppression of glioblastoma in mice: (A) Experimental design for the orthotopic injection of glioblastoma cel
AI learns to make sense of childhood cancer survivors' health care needs

AI learns to make sense of childhood cancer survivors' health care needs

bySt. Jude Children's Research HospitalCredit: SHVETS production from PexelsArtificial intelligence (AI) could help physicians determine if survivors of childhood cancer need extra support—and the

AI learns to make sense of childhood cancer survivors' health care needs

bySt. Jude Children's Research HospitalCredit: SHVETS production from PexelsArtificial intelligence (AI) could help physicians determine if survivors of childhood cancer need extra support—and the
Why some cancer therapies don't work for all patients: A tumor backup survival pathway

Why some cancer therapies don't work for all patients: A tumor backup survival pathway

by Anne Trafton,Massachusetts Institute of TechnologyMany of the targeted tumors turn on a backup survival pathway that helps them keep growing when tyrosine kinase—pictured here as strands—is turned

Why some cancer therapies don't work for all patients: A tumor backup survival pathway

by Anne Trafton,Massachusetts Institute of TechnologyMany of the targeted tumors turn on a backup survival pathway that helps them keep growing when tyrosine kinase—pictured here as strands—is turned